Catalysts for Genmab US Inc
5 tracked
Mar 27, 2026
approval
EPKINLY (EPCORITAMAB-BYSP) — FDA approval
epcoritamab
→
Nov 18, 2025
approval
EPKINLY (EPCORITAMAB-BYSP) — FDA approval
epcoritamab
→
Sep 11, 2025
approval
EPKINLY (EPCORITAMAB-BYSP) — FDA approval
epcoritamab
→
Jun 26, 2024
approval
EPKINLY (EPCORITAMAB-BYSP) — FDA approval
epcoritamab
→
May 19, 2023
approval
EPKINLY (EPCORITAMAB-BYSP) — FDA approval
epcoritamab
→